• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据菌株类型评估艰难梭菌感染的临床结局。一项医疗病房的前瞻性研究。

Clinical outcomes of Clostridium difficile infection according to strain type. A prospective study in medical wards.

机构信息

Internal Medicine Department, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Italy.

Epidemiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

出版信息

Eur J Intern Med. 2018 Aug;54:21-26. doi: 10.1016/j.ejim.2018.03.015. Epub 2018 Apr 9.

DOI:10.1016/j.ejim.2018.03.015
PMID:29650357
Abstract

OBJECTIVES

To describe clinical characteristics and outcome of Clostridium difficile infection (CDI) patients in Internal Medicine, to identify ribotypes (RTs); to evaluate the association between RT and patient clinical characteristics and report outcome.

METHODS

One year prospective cohort study. Clinical data, Barthel Index (BI) and outcomes were collected for all inpatients suffering from CDI (n = 148) in hospital wards in Northern Italy. 84 fecal samples were analysed for molecular typing.

RESULTS

12 RTs were identified, predominantly RT018 (42.9%, n = 36/84) and RT356/607 (40.5%, n = 34/84). Patients with dementia were more frequent among those infected by RT018 [55.6% (n = 20/36) vs. 32.4% (n = 11/34), p = 0.05]. The median BI score of patients with RT018 was lower than BI score of patients with RT356/607 [10 (IQR 0-32) vs. 15 (IQR 5-50), p = 0.06]. RT018 infection was associated to higher levels of C-reactive protein [7.2 mg/dl (IQR 4.1-14.7) vs. 4.0 mg/dl (IQR 2.2-6.8), p = 0.01] and white blood cells ≥15,000/dl [33.3% (n = 12/36) vs. 14.7% (n = 5/34) of patients, p = 0.07]. Higher mortality was noted among RT018 infected patients. We found a continuous mortality increase according to the ATLAS score.

CONCLUSIONS

Our results confirm that RT018 and RT356/607 are the two major RTs causing CDI in older patients with a high degree of disability in Northern Italy and RT018 is associated with more serious outcomes.

摘要

目的

描述内科住院患者艰难梭菌感染(CDI)的临床特征和结局,鉴定核糖型(RT);评估 RT 与患者临床特征的相关性,并报告结局。

方法

这是一项为期 1 年的前瞻性队列研究。在意大利北部的医院病房中,对所有患有 CDI(n=148)的住院患者收集临床数据、巴氏指数(BI)和结局。对 84 份粪便样本进行了分子分型分析。

结果

鉴定出 12 种 RT,主要为 RT018(42.9%,n=36/84)和 RT356/607(40.5%,n=34/84)。感染 RT018 的患者中痴呆更为常见[55.6%(n=20/36) vs. 32.4%(n=11/34),p=0.05]。感染 RT018 的患者 BI 评分中位数低于感染 RT356/607 的患者[10(IQR 0-32)vs. 15(IQR 5-50),p=0.06]。RT018 感染与更高的 C 反应蛋白水平相关[7.2mg/dl(IQR 4.1-14.7)vs. 4.0mg/dl(IQR 2.2-6.8),p=0.01]和白细胞计数≥15,000/dl[33.3%(n=12/36)vs. 14.7%(n=5/34),p=0.07]。RT018 感染患者的死亡率更高。我们发现,根据 ATLAS 评分,死亡率呈连续增加。

结论

我们的研究结果证实,RT018 和 RT356/607 是导致意大利北部老年、高残疾患者 CDI 的两种主要 RT,且 RT018 与更严重的结局相关。

相似文献

1
Clinical outcomes of Clostridium difficile infection according to strain type. A prospective study in medical wards.根据菌株类型评估艰难梭菌感染的临床结局。一项医疗病房的前瞻性研究。
Eur J Intern Med. 2018 Aug;54:21-26. doi: 10.1016/j.ejim.2018.03.015. Epub 2018 Apr 9.
2
Hospital outbreak due to Clostridium difficile ribotype 018 (RT018) in Southern Germany.德国南部因艰难梭菌 018 型(RT018)引起的医院感染。
Int J Med Microbiol. 2019 May-Jun;309(3-4):189-193. doi: 10.1016/j.ijmm.2019.03.001. Epub 2019 Mar 5.
3
High morbidity and mortality of Clostridium difficile infection and its associations with ribotype 002 in Hong Kong.香港艰难梭菌感染的高发病率和死亡率及其与 002 型的关联。
J Infect. 2016 Aug;73(2):115-22. doi: 10.1016/j.jinf.2016.05.010. Epub 2016 May 28.
4
Clinical features and characteristics of Clostridium difficile PCR-ribotype 176 infection: results from a 1-year university hospital internal ward study.艰难梭菌PCR核糖体分型176感染的临床特征:一项为期1年的大学医院内科病房研究结果
Ann Clin Microbiol Antimicrob. 2015 Dec 23;14:55. doi: 10.1186/s12941-015-0114-0.
5
Clostridium difficile PCR Ribotype 018, a Successful Epidemic Genotype.艰难梭菌PCR核糖体分型018,一种成功的流行基因型。
J Clin Microbiol. 2015 Aug;53(8):2575-80. doi: 10.1128/JCM.00533-15. Epub 2015 Jun 3.
6
Clostridium difficile ribotype 176 - A predictor for high mortality and risk of nosocomial spread?艰难梭菌核糖体分型176——高死亡率和医院内传播风险的预测指标?
Anaerobe. 2016 Aug;40:35-40. doi: 10.1016/j.anaerobe.2016.05.002. Epub 2016 May 4.
7
Whole-genome sequencing improves discrimination of relapse from reinfection and identifies transmission events among patients with recurrent Clostridium difficile infections.全基因组测序提高了对复发性艰难梭菌感染患者复发与再感染的区分能力,并鉴定了传播事件。
J Hosp Infect. 2015 Jun;90(2):108-16. doi: 10.1016/j.jhin.2015.01.021. Epub 2015 Feb 26.
8
Enhanced surveillance of Clostridium difficile infection occurring outside hospital, England, 2011 to 2013.强化监测英格兰地区 2011 至 2013 年发生在医院外的艰难梭菌感染。
Euro Surveill. 2016 Jul 21;21(29). doi: 10.2807/1560-7917.ES.2016.21.29.30295.
9
Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England.在英国引入基于核糖体分型的全国监测计划后,艰难梭菌感染的流行病学发生变化。
Clin Infect Dis. 2012 Oct;55(8):1056-63. doi: 10.1093/cid/cis614. Epub 2012 Jul 11.
10
Occurrence of Clostridium difficile ribotype 027 in hospitals of Silesia, Poland.波兰西里西亚医院艰难梭菌核糖体分型027的出现情况。
Anaerobe. 2017 Jun;45:106-113. doi: 10.1016/j.anaerobe.2017.02.002. Epub 2017 Feb 12.

引用本文的文献

1
Comparison of the STANDARD M10 . , Xpert . , and BD MAX Cdiff assays as confirmatory tests in a two-step algorithm for diagnosing infection.将标准M10、Xpert和BD MAX艰难梭菌检测作为两步诊断算法中感染确认试验的比较。
Microbiol Spectr. 2025 Jan 7;13(1):e0166224. doi: 10.1128/spectrum.01662-24. Epub 2024 Nov 29.
2
Penicillin Binding Protein Substitutions Cooccur with Fluoroquinolone Resistance in Epidemic Lineages of Multidrug-Resistant Clostridioides difficile.青霉素结合蛋白取代与氟喹诺酮耐药性共同存在于多重耐药艰难梭菌的流行谱系中。
mBio. 2023 Apr 25;14(2):e0024323. doi: 10.1128/mbio.00243-23. Epub 2023 Apr 5.
3
Infection: An Epidemiology Update.
感染:流行病学最新进展
Clin Colon Rectal Surg. 2020 Mar;33(2):49-57. doi: 10.1055/s-0040-1701229. Epub 2020 Feb 25.